Literature DB >> 15541730

A basic peptide within the juxtamembrane region is required for EGF receptor dimerization.

Sami Aifa1, Jan Aydin, Gunnar Nordvall, Ingemar Lundström, Samuel P S Svensson, Ola Hermanson.   

Abstract

The epidermal growth factor receptor (EGFR) is fundamental for normal cell growth and organ development, but has also been implicated in various pathologies, notably tumors of epithelial origin. We have previously shown that the initial 13 amino acids (P13) within the intracellular juxtamembrane region (R645-R657) are involved in the interaction with calmodulin, thus indicating an important role for this region in EGFR function. Here we show that P13 is required for proper dimerization of the receptor. We expressed either the intracellular domain of EGFR (TKJM) or the intracellular domain lacking P13 (DeltaTKJM) in COS-7 cells that express endogenous EGFR. Only TKJM was immunoprecipitated with an antibody directed against the extracellular part of EGFR, and only TKJM was tyrosine phosphorylated by endogenous EGFR. Using SK-N-MC cells, which do not express endogenous EGFR, that were stably transfected with either wild-type EGFR or recombinant full-length EGFR lacking P13 demonstrated that P13 is required for appropriate receptor dimerization. Furthermore, mutant EGFR lacking P13 failed to be autophosphorylated. P13 is rich in basic amino acids and in silico modeling of the EGFR in conjunction with our results suggests a novel role for the juxtamembrane domain (JM) of EGFR in mediating intracellular dimerization and thus receptor kinase activation and function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15541730     DOI: 10.1016/j.yexcr.2004.08.032

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  27 in total

1.  Calmodulin binds HER2 and modulates HER2 signaling.

Authors:  Colin D White; Zhigang Li; David B Sacks
Journal:  Biochim Biophys Acta       Date:  2010-12-24

2.  The juxtamembrane region of the EGF receptor functions as an activation domain.

Authors:  Monica Red Brewer; Sung Hee Choi; Diego Alvarado; Katarina Moravcevic; Ambra Pozzi; Mark A Lemmon; Graham Carpenter
Journal:  Mol Cell       Date:  2009-06-26       Impact factor: 17.970

3.  An electrostatic engine model for autoinhibition and activation of the epidermal growth factor receptor (EGFR/ErbB) family.

Authors:  Stuart McLaughlin; Steven O Smith; Michael J Hayman; Diana Murray
Journal:  J Gen Physiol       Date:  2005-06-13       Impact factor: 4.086

4.  Regulation of the ligand-dependent activation of the epidermal growth factor receptor by calmodulin.

Authors:  Hongbing Li; Svetlana Panina; Amandeep Kaur; María J Ruano; Pablo Sánchez-González; Jonas M la Cour; Alexander Stephan; Uffe H Olesen; Martin W Berchtold; Antonio Villalobo
Journal:  J Biol Chem       Date:  2011-12-08       Impact factor: 5.157

5.  Identification of in vitro autophosphorylation sites and effects of phosphorylation on the Arabidopsis CRINKLY4 (ACR4) receptor-like kinase intracellular domain: insights into conformation, oligomerization, and activity.

Authors:  Matthew R Meyer; Cheryl F Lichti; R Reid Townsend; A Gururaj Rao
Journal:  Biochemistry       Date:  2011-02-16       Impact factor: 3.162

6.  Phosphatidylinositol-4,5-bisphosphate regulates epidermal growth factor receptor activation.

Authors:  Ioannis E Michailidis; Radda Rusinova; Anastasios Georgakopoulos; Yibang Chen; Ravi Iyengar; Nikolaos K Robakis; Diomedes E Logothetis; Lia Baki
Journal:  Pflugers Arch       Date:  2010-11-24       Impact factor: 3.657

7.  The effect of hydrophilic substitutions and anionic lipids upon the transverse positioning of the transmembrane helix of the ErbB2 (neu) protein incorporated into model membrane vesicles.

Authors:  Khurshida Shahidullah; Shyam S Krishnakumar; Erwin London
Journal:  J Mol Biol       Date:  2009-11-18       Impact factor: 5.469

Review 8.  The ErbB kinase domain: structural perspectives into kinase activation and inhibition.

Authors:  Ron Bose; Xuewu Zhang
Journal:  Exp Cell Res       Date:  2008-08-15       Impact factor: 3.905

9.  Anti-EGFR Therapy: Mechanism and Advances in Clinical Efficacy in Breast Cancer.

Authors:  John F Flynn; Christina Wong; Joseph M Wu
Journal:  J Oncol       Date:  2009-04-14       Impact factor: 4.375

10.  Structure-function analysis of nucleolin and ErbB receptors interactions.

Authors:  Keren Farin; Ayelet Di Segni; Adam Mor; Ronit Pinkas-Kramarski
Journal:  PLoS One       Date:  2009-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.